Year: 2014

Maria’s GentleWhispering YouTube channel triggers “tingles” in those with ASMR.

WASHINGTON (AP) — A growing share of Americans got health insurance as sign-up season for President Barack Obama's health care law came to a close last month, a major survey released Monday has found.

By Lawrence Hurley WASHINGTON (Reuters) – Teva Pharmaceutical Industries Ltd asked the U.S. Supreme Court on Monday to stop a lower court ruling from going into effect while the justices consider an appeal in a patent fight over Teva's top-selling multiple sclerosis drug Copaxone. On March 31, the high court agreed to hear Teva's appeal of a July 2013 ruling by the U.S. Court of Appeals for the Federal Circuit in favor of two teams developing cheaper generic forms of Copaxone: one involving Novartis AG's Sandoz Inc and Momenta Pharmaceuticals Inc, and the other involving Mylan Inc and Natco Pharma Ltd. The appeals court had upheld some of the nine patents involved in the drug, or portions of them, but declared several invalid, meaning patent protections were set to expire in May 2014 instead of September 2015.

To get all the health benefits of low glycemic foods, Americans would have to … But claims that the diet helps with weight loss remain largely unproven.

Former Massachusetts Senator Scott Brown, who has been mulling a Senate run in New Hampshire for the past few months, plans formally to announce his campaign on Thursday, the Republican said in a letter to supporters on Monday. National Republican supporters have moved quickly to buy ads supporting Brown’s potential run against incumbent Democrat Jeanne Shaheen, seeing the race as an opportunity to shrink Democrats’ 55-43 majority in the upper chamber. Brown, who has focused much of his recent public statements on his opposition to President Barack Obama’s healthcare reform law, said in an e-mail to supporters that his weeks of canvassing the state convinced him that “you want a health care system that works for New Hampshire.” “Together, we can do all this, but it starts by changing leadership in Washington,” said Brown, who was a little-known Massachusetts state senator before he stunned the state’s Democratic party to win the U.S. Senate seat previously held by Edward M. Kennedy in 2010.

Just as bracelets such as Fitbit are beginning to catch on, researchers have developed an even more discreet wearable health monitoring device. A new skin patch is able to track various health indicators and send data wirelessly to a PC or smartphone. This next-generation health tracking device was developed by researchers at the University of Illinois at Urbana-Champaign and at Northwestern University under the direction of John A. Rogers and Yonggang Huang. Designed to keep tabs on the wearer's health at all times, the patch has various applications, from tracking muscular activity to monitoring symptoms related to an illness.

(Reuters) – A mid-stage trial of Puma Biotechnology’s experimental drug neratinib showed that it was more effective, given before surgery, than Herceptin, the Roche drug commonly used in women with a type of breast cancer fueled by a protein called HER2. About 39 percent of HER2 patients given a combination of neratinib and chemotherapy achieved a “pathologic complete response,” compared with 23 percent of women treated with chemo and Herceptin. The trial also found that the experimental drug resulted in a higher rate of pCR, 45 percent, than standard care, 29 percent, in women with tumors for which genetic testing indicated a high probability that their cancer would return. Alan Auerbach, Puma’s chief executive officer, said the company is in the process of designing Phase 3 trials of neratinib in both HER2-positive patients and in patients with a high risk of breast cancer recurrence.